Amanda and I went to New Orleans and presented our work on KRAS mutant-selective therapies at the FASEB Cell Signaling Conference. We were joined by other MUSC faculty John O'Bryan and Saverio Gentile. The keynote speaker was Dr. Channing Der of UNC and there were many notable attendees. Our hotel was right on Bourbon Street and the conference organizers did an excellent job on creating a collaborative and inviting atmosphere.
Comments